FASEB Board of Directors (July 2017 - June 2018)
Thomas O. Baldwin, PhD
Professor of Biochemistry
University of California
James M. Musser, MD, PhD
Fondren Distinguished Presidential Endowed Chair,
Department of Pathology and Genomic Medicine and
Director, Center for Molecular and Translational Human Infectious Diseases Research,
Houston Methodist Hospital and Research Institute
Immediate Past President
Hudson H. Freeze, PhD
Professor of Glycobiology
Director, Human Genetics Program
Sanford Children's Health Research Center
Sanford-Burnham-Prebys Medical Discovery Institute
La Jolla, California
Vice President for Science Policy
Hannah V. Carey, PhD
Department of Comparative Biosciences
Unviersity of Wisconsin
School of Veterinary Medicine
David M. Rocke, PhD
Distinguished Professor in the Division of Biostatistics
Department of Public Health Sciences (School of Medicine) and
Department of Biomedical Engineering (College of Engineering)
University of California, Davis
Vice President-Elect for Science Policy
Louis B. Justement, PhD
Professor, Department of Microbiology
University of Alabama at Birmingham
Immediate Past Vice President for Science Policy
Scott I. Simon, PhD
Department of Biomedical Engineering
University of California, Davis
Chester A. Ray, PhD
Professor and Chair
Department of Nutrition, Food, and Exercise Science
Director, Institute of Sports Sciences and Medicine
Florida State University
Frank Krause, CAE
Frank J. Krause, Jr., is the Executive Director and Chief Executive Officer of FASEB. Krause supports and works with the Board of Directors to fulfill the Federation’s mission and goals, and he leads staff in the execution of these goals, all the while cultivating myriad relationships with member societies and external partners.
A Certified Association Executive, Krause has worked in the association and society industry for 13 years – most recently as the Chief Operating Officer of the American Geophysical Union (AGU) leading various organizational transitions in publishing, meetings, association management, and the renovation of the AGU's Headquarters building. He utilizes his prior experience in the for-profit sector to deliver increased levels of member value through streamlining and enhancing operations, developing new products and services, and promoting member-centric cultures. Prior to joining the AGU, Krause served in various senior executive roles at the American Medical Association (AMA) leading the publishing business, physician database management, and customer service teams. His for profit experience comes from 16 years at RR Donnelley & Sons serving in various executive and engineering roles.
Krause holds a Masters of Business Administration from the Kellogg School of Management at Northwestern University, and a Bachelors degree in Electrical Engineering from the University of Illinois, Champaign-Urbana.
FASEB Executive Director
9650 Rockville Pike
Board Members Representing FASEB Member Societies
American Aging Association - AGE
Matt Kaeberlein, PhD
Dr. Matt Kaeberlein is a Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington. He is a member of the Board of Directors, the Executive Committee, and a past-President of the American Aging Association (AGE). Dr. Kaeberlein represents AGE on the FASEB Board of Directors.
Dr. Kaeberlein obtained a Bachelor of Science in Biochemistry and a Bachelor of Arts in Mathematics from Western Washington University in 1997, a Ph.D. in Biology from the Massachusetts Institute of Technology in 2002, and joined the faculty at the University of Washington in 2006. Dr. Kaeberlein’s research interests have been focused on understanding the fundamental mechanisms of aging and age-related disease. His work encompasses basic geroscience using yeast, worm, and mouse models and clinical geroscience in companion dogs. He has published more than 150 papers in top scientific journals, and his research and mentoring accomplishments have been recognized by several awards, including a Breakthroughs in Gerontology Award, an Alzheimer’s Association Young Investigator Award, an Ellison Medical Foundation New Scholar in Aging Award, an Undergraduate Research Mentor of the Year Award, the Nelson Fausto Distinguished Mentor Award, a Murdock Trust Award, and the Vincent Cristofalo Rising Star in Aging Research Award. Dr. Kaeberlein has also been awarded Fellow status with both the Gerontological Society of America and the American Aging Association.
Dr. Kaeberlein currently serves on the editorial boards for Science, Geroscience, Translational Medicine of Aging, npj Aging and Mechanisms of Disease, Cell Cycle, Oncotarget, BioEssays, Frontiers in Genetics of Aging, F1000 Research, and Ageing Research Reviews. In addition to his primary appointment, Dr. Kaeberlein served as a Distinguished Visiting Professor of Biochemistry at the Aging Research Institute of Guangdong Medical College in Dongguan, China from 2009-2014. He is currently the co-Director of the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging, the founding Director of the Healthy Aging and Longevity Research Institute at the University of Washington, and co-Director of the Dog Aging Project.
Professor of Pathology
Adjunct Professor Genome Sciences
Adjunct Professor of Oral Health Sciences
The University of Washington
American Association of Anatomists - AAA
David Burr, PhD
Associate Vice Chancellor for Research (IUPUI)
Indiana University School of Medicine
Department of Anatomy and Cell Biology & Biomedical Engineering
The American Association of Immunologists - AAI
Louis B. Justement, PhD
Professor, Department of Microbiology
University of Alabama at Birmingham
American College of Sports Medicine - ACSM
William B. Farquhar, PhD, FACSM
William B. Farquhar, PhD, FACSM, is a Professor in the Department of Kinesiology & Applied Physiology at the University of Delaware, with a joint appointment in the Department of Biological Sciences. He is a Fellow of the American College of Sports Medicine and member of the American Physiological Society.
Dr. Farquhar served as chair of the Department of Kinesiology & Applied Physiology from 2011 – 2017. He currently serves as a Board of Trustee and administrative council member of the American College of Sports Medicine. He serves on the Editorial Boards of Autonomic Neuroscience: Basic and Clinical and the Journal of Applied Physiology, and he is member of an NIH study section.
Dr. Farquhar’s research expertise is in the area of cardiovascular health as it relates to diet and exercise. NIH has funded his research since 2003. Dr. Farquhar teaches Advanced Mammalian Physiology and Advanced Exercise Physiology.
Department of Kinesiology and Applied Physiology
College of Health Sciences
University of Delaware
American Federation for Medical Research - AFMR
Robert J. Freishtat, MD, MPH
Associate Chief for Academic Affairs, Division of Emergency Medicine
Children's national Health System
Associate Professor of Pediatrics, Emergency Medicine and Integrative Systems Biology
George Washington University School of Medicine and Health Sciences
American Peptide Society - APEPS
Philip E. Dawson, PhD
Philip Dawson is a Professor of Chemistry at The Scripps Research Institute (TSRI) in La Jolla, CA and the Dean of Graduate and Postdoctoral Studies. He received an A.B. in Chemistry from Washington University in St. Louis (1992) and a Ph.D. from TRSI (1996). After pursuing postdoctoral work at the California Institute of Technology, he joined the TSRI faculty in 1997. In 2011, Dr. Dawson joined the Dean’s Advisory Committee and, in 2012, became Associate Dean of Graduate Studies. In 2017, Dr. Dawson became Dean of Graduate and Postdoctoral Studies. He has been a member of the council of the American Peptide Society since 2007 as councilor (2007-2013) and as President Elect (2013-15) and President (2015-17).
Dr. Dawson is an expert in the area of chemoselective ligation and was an inventor of the widely used native chemical ligation approach for the synthesis and semisynthesis of proteins. His laboratory has developed new approaches for bioconjugation, including aniline catalysis, which facilitates the synthesis of complex molecules such as vaccines and antibody-drug conjugates. The Dawson lab has used these methods to synthesize a variety of proteins to study protein folding and topology, enzymatic catalysis, homogeneous glycoproteins and mimics of the coat proteins from pathogenic viruses. His laboratory utilizes these methods for the structure based design of immunogens, the development of protein therapeutics, functionalization of nanoparticles for biological imaging and therapies for lysosomal storage diseases.
Dr. Dawson is the current Past President of the American Peptide Society (2017-2019), was co-chairman of both the 22nd American Peptide Symposium (2011) and the GRC on the Chemistry and Biology of Peptides (2016). He has published over 160 papers, and has been honored with an Alfred P. Sloan Foundation fellowship, the Vincent du Vigneaud Award, the Max Bergmann Kreis Gold Medal and the Zervas award.
Professor of Chemistry and Dean of Graduate and Postdoctoral Studies
The Scripps Research Institute
La Jolla, California
American Society for Biochemistry and Molecular Biology - ASBMB
C. Robert Matthews, PhD
Arthur F. and Helen P. Koskanis Professor, Biochemistry and Molecular Pharmacology
Chair, Department of Biochemistry and Molecular Pharmacology
University of Massachusetts Medical School
American Society for Bone and Mineral Research - ASBMR
Roberto Civitelli, MD
Chief of the Division of Bone and Mineral Disease
Director of the Washington University Skeletal Disorders Training Program
Washington University - St. Louis School of Medicine
St. Louis, Missouri
American Society for Clinical Investigation - ASCI
Talat Alp Ikizler, MD
Catherine McLaughlin Hakim Professor of Medicine
Director of Clinical Research in Nephrology
Director, Master of Science in Clinical Investigation Program
Vanderbilt University School of Medicine
The American Society of Human Genetics - ASHG
Aravinda Chakravarti, PhD
Aravinda Chakravarti, Ph.D. is Professor of Medicine, Pediatrics, Molecular Biology & Genetics, and, Biostatistics at the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health. He was the 2008 President of the American Society of Human Genetics, and has been elected to the US National Academy of Science, the US National Academy of Medicine, the Indian National Academy of Sciences and the Indian Academy of Sciences. He has been a key participant and architect of the Human Genome, HapMap and 1000 Genomes project. His research is aimed at genome-scale analysis of humans and computational analysis of gene variation and function to understand the molecular genetic basis of complex human disease. For his contributions to human genetics and genomics he was awarded the William Allan Award in 2013 by the American Society of Human Genetics.
Aravinda Chakravarti received his doctoral degree in human genetics in 1979 and started his faculty career at the University of Pittsburgh (1980 – 1993), was the James H. Jewell Professor of Genetics at Case Western Reserve University (1994- 2000), and the inaugural Director and Henry J. Knott Professor of the McKusick- Nathans Institute of Genetic Medicine at Johns Hopkins (2000-2007). He is one of the founding Editors-in-Chief of Genome Research and Annual Reviews of Genomics & Human Genetics, and serves on the boards of numerous private Institutes and charities, international journals, academic societies, the NIH and biotechnology companies.
Professor of Genetic Medicine
Johns Hopkins University School of Medicine
McKusick-Nathans Institute of Genetic Medicine
American Society for Investigative Pathology - ASIP
Charles A. Parkos, MD, PhD
Charles Parkos, MD, PhD is the Carl V. Weller Professor and Chair of the Department of Pathology at the University of Michigan Medical School. He received his MD/PhD degree from the University of California at San Diego and Scripps Research Institute in 1987, where his studies centered on determining the molecular basis of reactive oxygen species generation by neutrophils and identification of the molecular defect in Chronic Granulomatous Disease. In 1988, Dr. Parkos began residency and fellowship training in Pathology at Brigham and Women’s Hospital, with sub specialization in diagnostic gastrointestinal surgical pathology. While at Harvard Medical School, he began investigating fundamental mechanisms of dysregulated leukocyte trafficking across the intestinal mucosa, as observed in people with Inflammatory Bowel Disease (IBD). Dr. Parkos received his first independent NIH grant in 1995 and has been continuously R01-funded by multiple grants for over 25 years. In 1997, he was recruited to Emory University School of Medicine as a senior faculty member and Director of the Division of Gastrointestinal Pathology, and became a full Professor in 2003. In 2008 he was appointed Vice Chair in the Department of Pathology and Laboratory Medicine and Director of Experimental Pathology at Emory University School of Medicine. In September 2014 he was recruited to the University of Michigan Medical School as Chair of Pathology.
In the laboratory, Dr. Parkos has had a career-long interest in elucidating mechanisms of inflammatory bowel disease, expanding his interests to identification of molecular mechanisms guiding neutrophil trafficking through the mucosa, and specifically across the intestinal epithelium. His studies have been instrumental in gaining a clearer and more precise understanding of how neutrophils and other leukocyte populations find, adhere, and migrate across the intestinal epithelium. Dr. Parkos has used state-of-the-art molecular and cell-based approaches in complex cell biological systems to elucidate the roles of many epithelial and neutrophil proteins in regulating leukocyte trafficking across the intestinal mucosa and how interactions influence epithelial barrier function. During his career, Dr. Parkos has published more than 189 scientific manuscripts, many in outstanding journals such as Proc Nat Acad Sci, J Exp Med, Immunity, Cell, Nature, J Cell Biol, J Clin Invest, Mucosal Immunology, Gastroenterology, and Mol Biol Cell, and is a regularly invited speaker at international symposia related to his field.
In addition to his research, Dr. Parkos has a longstanding commitment to teaching, training, and mentorship at all levels, including graduate and medical students, postdoctoral fellows, and junior faculty. Many of whom have gone on to highly successful academic careers in related areas. He had senior leadership positions in Emory University’s Medical Scientist Training Program where he served as a co-director from 2001 to 2006 followed by appointment as Director until leaving Emory in 2014. During this time, the MD/PhD program experienced significant growth to 88 students. During this time, Dr. Parkos demonstrated a high level of commitment to service, promoting research in the areas of experimental pathology and mucosal immunology. His efforts to promote the discipline of experimental pathology resulted in his election to, and service in, the roles of Vice President (2008-2009), President Elect (2009-2010) and President (2010-2011) of The American Society of Investigative Pathology (ASIP). At the same time, he has also been a strong advocate for the Crohn’s and Colitis Foundation of America in promoting basic research directed at better understanding the pathogenesis of Inflammatory Bowel Disease. Since 2000, he served for six years on senior research grant review committees, and recently finished a three-year term as chair of the research committee that scientifically reviews all CCFA Fellowship and Career Development Awards.
Carl V. Weller Professor and Chair
Department of Pathology
University of Michigan
Ann Arbor, Michigan
American Society for Nutrition - ASN
Kelly A. Tappenden, PhD, RD, FASPEN
Professor of Nutrition and Gastrointestinal Physiology
University of Illinois at Urbana-Champaign
Division of Nutritional Sciences
American Society for Pharmacology and Experimental Therapeutics - ASPET
Brian M. Cox, PhD
Professor of Pharmacology and Neuroscience
University of the Health Sciences
Department of Pharmacology
Association of Biomolecular Resource Facilities - ABRF
Sheenah Mische, PhD
Office of Collaborative Science
NYU School of Medicine
NYU Langone Medical Center
New York, New York
Association for Molecular Pathology - AMP
Betsy A. Bove, PhD
Betsy A. Bove, PhD, is the Vice President of Laboratory Regulation Compliance and the Assistant Laboratory Director at Genomind, Inc. in King of Prussia, PA. She is helping to meet the technical and regulatory challenges of a new personalized medicine clinical service offering pharmacogenetics testing used presently by neurologist and psychiatrists as a tool to assist in patient care. Betsy oversees the regulatory and technical responsibilities of the laboratory as well as the personnel management, and with the Director evaluates and reports clinical testing data results under the standards of CAP/CLIA/NYS accreditation.
Betsy received her BA in Biological Sciences from the University of Delaware in 1978, and her Ph.D. in Genetics and Molecular Biology in 1996. She completed her postdoctoral training in breast cancer research and in clinical molecular pathology at the Fox Chase Cancer Center in Philadelphia, PA. Dr. Bove was a founding partner of the Clinical Molecular Genetics Laboratory at the Fox Chase Cancer Center, and served as laboratory manager and director designee until 2012. She consulted until 2015 for other cancer centers to assist in initiating clinical molecular laboratory pathology service, and for private industry offering expertise in technical service and marketing.
Her interests have been associated with the molecular pathology of solid tumors, translational molecular testing development and validation, and disease association with germline SNP genotyping in support of personalized medicine. Dr. Bove has served on numerous committees for AMP, CLSI, CCCLW, and FASEB. She joined the FASEB board in 2017 and is a member of the Science Policy Committee.
Assistant Laboratory Director
The American Physiological Society - APS
Kevin C. Kregel, PhD
Kevin C. Kregel, PhD is the Associate Provost for Faculty, and Professor of Human Physiology, at the University of Iowa (UI). Dr. Kregel received a PhD (Physiology & Biophysics, Carver College of Medicine) from The University of Iowa (UI). He then moved to the University of Arizona, where he performed an NIH postdoctoral fellowship and subsequently became a faculty member. Dr. Kregel joined the faculty at UI in 1993, and served as the Chair of the newly created Department of Health & Human Physiology for several years prior to his appointment as Associate Provost.
Dr. Kregel’s research is focused on physiological adaptation to stressors, especially related to challenges such as exercise and heat stress, and his research program has consistently been funded by the NIH, Department of Defense and other external agencies. He also collaborates with colleagues in the UI’s Virtual Soldier Research Program in the Center for Computer-Aided Design in merging human physiological testing with physics-based digital human modeling and simulation tools for the development of predictive models for enhanced performance and injury prevention. As Associate Provost for Faculty, he oversees a wide range of faculty research, development and diversity programs, as well as campus-wide faculty recruitment, review, promotion, and retention efforts.
Dr. Kregel has been a member of FASEB’s Science Policy Committee (SPC) since 2014, and has chaired the SPC Animal Issues in Research and Education subcommittee since 2008. He is also past-chair of the Science Policy Committee of the American Physiological Society. In addition to his FASEB service, he has been a member of several national and international review panels, advisory councils, and oversight committees, and served as an associate editor of several leading journals in the physiological science area for over 20 years.
Associate Provost for Faculty
Professor of Human Physiology
University of Iowa
Iowa City, Iowa
Biomedical Engineering Society - BMES
To be announced.
Endocrine Society - ES
Ursula B. Kaiser, MD
Professor of Medicine
Harvard Medical School
Brigham and Women's Hospital
Chief, Division of Endocrinology, Diabetes, and Hypertension
Genetics Society of America - GSA
Jasper D. Rine, PhD
Professor of Genetics
Department of Genomics/Development
University of California, Berkeley
The Histochemical Society - HCS
Charles W. Frevert, DVM, ScD
Department of Comparative Medicine
University of Washington School of Medicine
International Society for Computational Biology - ISCB
Terry Gaasterland, PhD
Professor of Computational Biology & Genomics
Scripps Institution of Oceanography and
Institute for Genomic Medicine
University of California, San Diego
La Jolla, California
The Protein Society - PS
David P. Goldenberg, PhD
Professor of Biology
The Goldenberg Lab
Department of Biology
University of Utah
Salt Lake City, Utah
Society for Developmental Biology - SDB
Lee Niswander, PhD
University of Colorado School of Medicine
Anschutz Medical Campus
Society for Experimental Biology and Medicine - SEBM
David Boothman, PhD
Professor of Pharmacology and Radiation Oncology
Associate Director for Translational Research, Simmons Comprehensive Cancer Center
Robert B. and Virginia Payne Professorship in Oncology
University of Texas Southwestern Medical Center
Society for Redox Biology and Medicine - SFRBM
Eric E. Kelley, PhD
Associate Professor of Physiology and Pharmacology, West Virginia University
Morgantown, West Virginia
The Society for Glycobiology - SfG
Gerald W. Hart, PhD
Gerald Warren Hart, Ph.D., is the Paul & Christine Englund Professor and Director of Biological Chemistry at Johns Hopkins. He has served as the Director of Biological Chemistry for ~20 years. He is an Associate Editor of J. Biological Chemistry and of Molecular and Cellular Proteomics and an Editor of BBRC. He founded the journal Glycobiology in 1989, now the leading journal in the field and served as its Editor-In-Chief for 12 years. During his graduate career, he performed some of the earliest studies on cell surface heparan sulfates and on the roles of proteoglycans and sulfotransferases in corneal transparency. During his postdoctoral work, he determined the minimal sequence requirement for N-glycosylation (-Asn-X-Ser-) and showed that corneal keratin sulfate is made via the N-glycan biosynthetic pathway. Hart’s laboratory discovered O-GlcNAcylation, he co-led elucidation of GPI anchor biosynthesis with Paul Englund’s group, and his lab documented the importance of protein structure for N-glycosylation. His lab discovered the extensive crosstalk between O-GlcNAc and phosphorylation, which regulates transcription and signaling and underlies the etiology of diabetes, neurodegenerative disease, cardiovascular disease and cancer. ~297 publications; Google H-factor = 105; i10-index=268.
Paul and Christine Englund Professor & Director
Department of Biological Chemistry
Johns Hopkins University
School of Medicine
The Society for Pediatric Research - SPR
Vivek Balasubramaniam, MD
Associate Professor of Pediatrics
Division Chief Pediatric Pulmonology and Sleep Medicine
University of Wisconsin, Madison
Society for the Study of Reproduction - SSR
Patricia L. Morris, PhD
Executive Director of Biomedical Research and Development, R&D, in the Reproductive Health Program Population Council's Center for Biomedical Research
New York, New York
Society of Toxicology - SOT
John B. Morris Ph.D.
Dr. Morris is a Board of Trustees Distinguished Professor Emeritus at the University of Connecticut. He joined the faculty of the University of Connecticut Toxicology Program in 1981 and served as the director of the program from 2000–2010. He served as the head of the Pharmaceutical Sciences Department (2002–2010), assistant dean for research (2008–2013) and Interim Dean of the School of Pharmacy (2013-2014) at the University.
Dr. Morris received his B.S. degree in Chemistry from Allegheny College in 1973. He received M.S. and Ph.D. degrees in Toxicology from the University of Rochester and did postdoctoral work from 1979-1981 at the New York University School of Medicine Institute of Environmental Medicine. He maintains active research interests in inhalation toxicology. His primary areas of expertise focus on the pulmonary health effects of irritant air pollutants and on quantitative inhalation risk assessment. His work has been extensively funded by the National Institutes of Health as well as the private sector. He has authored approximately 100 papers and book chapters in the field. His research publications have received many awards including Faculty of 1000 recognition for being among the top 2% of publications in biomedical literature for his work on the counter-irritant effects of menthol in cigarette smoke.
Dr. Morris has been very active in the Society of Toxicology and in addition to many other roles served as Treasurer (2011-2013) and President (2016-2017) of the society. He served on the editorial boards of Fundamental and Applied Toxicology, Toxicological Sciences, and Inhalation Toxicology and on the TOX-2 and ALTOX-4 study sections for NIH. He has served on air pollutant health assessment review panels for the states of Connecticut, Vermont, and Virginia, as well as for the US Environmental Protection Agency, Centers for Disease Control Agency for Toxic Substances and Disease Registry, and the Department of Energy Office of Health and Environmental Research, and has served on several National Academy of Sciences panels.
Board of Trustees Distinguished Professor Emeritus
University of Connecticut
Teratology Society - TS
Christine Perdan Curran, PhD
Northern Kentucky University
Department of Biological Sciences
Highland Heights, Kentucky
US Human Proteome Organization - US HUPO
Ralph A. Bradshaw, PhD
Department of Physiology & Biophysics
University of California - Irvine
Department of Pharmacology
University of California
San Diego, California